Kaposi's sarcoma and human herpesvirus-8.
KS is a major cause of morbidity and mortality among AIDS patients and a treatment problem in the sporadic cases that are not associated with HIV. All four forms of the disease are linked to a newly described herpesvirus, HHV-8 or KSHV, via strong epidemiologic associations and biologic plausibility as a causal agent. HHV-8 is also epidemiologically associated with body cavity-based lymphomas, which are almost unique to AIDS, and Castleman's disease. Existing radiation and chemotherapeutic treatments of KS are only partially effective and cause significant adverse effects. New preventive approaches and therapies aimed at inhibiting HHV-8 may be effective. New treatments that interfere with the molecular mechanisms that drive KS may, in the future, provide the best opportunities to control the disease.
Greenblatt
R M
RM
Infectious Diseases Division, University of California San Francisco, USA.
D017088:AIDS-Related Opportunistic Infections / Q000821:virology; D000328:Adult; D000349:Africa / Q000453:epidemiology; D000970:Antineoplastic Agents / Q000627:therapeutic use; D000998:Antiviral Agents / Q000627:therapeutic use; D002648:Child; D019049:Developed Countries; D019288:Herpesvirus 8, Human; D006801:Humans; D009369:Neoplasms / Q000209:etiology / Q000821:virology; D012514:Sarcoma, Kaposi / Q000175:diagnosis / Q000453:epidemiology* / Q000821:virology
D000970:Antineoplastic Agents; D000998:Antiviral Agents